Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Ahva Shahabi"'
Autor:
Gary R, Lichtenstein, Ahva, Shahabi, Seth A, Seabury, Darius N, Lakdawalla, Oliver Díaz, Espinosa, Sarah, Green, Michelle, Brauer, Robert N, Baldassano
Publikováno v:
Gastroenterol Hepatol (N Y)
Patients with Crohn’s disease (CD) or ulcerative colitis (UC) have high morbidity rates owing to debilitating intestinal complications and extraintestinal manifestations (EIMs). We retrospectively identified patients in the Truven MarketScan databa
Autor:
Mark T. Linthicum, James Baumgardner, Ahva Shahabi, Darius N. Lakdawalla, Seanna Vine, Christopher Zacker
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 24:504-513
Previous research finds significant variation in spending and utilization across regions, with little evidence of differences in outcomes. While such findings have been interpreted as evidence that spending can be reduced without compromising patient
Autor:
Ahva Shahabi, Tammy Curtice, Jason Shafrin, Alexander Marshall, Damemarie Paul, Lauren Zhao, Sarah Green
Publikováno v:
Journal of medical economics. 22(4)
To estimate real world healthcare costs and resource utilization of rheumatoid arthritis (RA) patients associated with targeted disease modifying anti-rheumatic drugs (tDMARD) switching in general and switching to abatacept specifically.RA patients i
Publikováno v:
The American journal of managed care. 24(12)
This study seeks to identify service categories that present the greatest opportunities to reduce spending in oncology care episodes, as defined by the CMS Oncology Care Model (OCM). Regional variation in spending for similar patients is often interp
Publikováno v:
Journal of oncology practice. 14(11)
Purpose: Performance-based payments to oncology providers participating in the Centers for Medicare & Medicaid Services (CMS) Oncology Care Model (OCM) are based, in part, on overall spending in 6-month episodes of care, including spending unrelated
Autor:
Jie Ren, Jian-Bing Fan, Inderbir S. Gill, Joseph G. Hacia, Siamak Daneshmand, Mariana C. Stern, Ahva Shahabi, Andy Sherrod, Jacek Pinski, Craig April, Juan Pablo Lewinger
Publikováno v:
The Prostate. 76:1239-1256
BACKGROUND Current clinical tools have limited accuracy in differentiating patients with localized prostate cancer who are at risk of recurrence from patients with indolent disease. We aimed to identify a gene expression signature that jointly with c
Autor:
Robert N. Baldassano, Gary R. Lichtenstein, Ahva Shahabi, Oliver Díaz Espinosa, Seth A. Seabury, Michelle Brauer, Sarah Green, Darius N. Lakdawalla
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 18(4)
Background & Aims Understanding the burden of Crohn’s disease (CD) and ulcerative colitis (UC) is important for measuring treatment value. We estimated lifetime health care costs incurred by patients with CD or UC by age at diagnosis. Methods We co
Publikováno v:
PharmacoEconomics Open
Background The variability in cost of palivizumab treatment, indicated for prevention of respiratory syncytial virus (RSV) infections in high-risk infants, has not been robustly estimated in prior studies. This study aimed to determine the cost varia
Autor:
Seth A. Seabury, Michelle Brauer, Sarah Green, Oliver Díaz Espinosa, Robert N. Baldassano, Ahva Shahabi, Gary R. Lichtenstein, Darius N. Lakdawalla
Publikováno v:
American Journal of Gastroenterology. 112:S395-S396
Autor:
Michelle Brauer, Sarah Green, Seth A. Seabury, Robert N. Baldassano, Ahva Shahabi, Oliver Díaz Espinosa, Gary R. Lichtenstein, Darius N. Lakdawalla
Publikováno v:
American Journal of Gastroenterology. 112:S395-S396